Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof
NZ836922APending Publication Date: 2026-09-25REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- NZ836922
- Authority / Receiving Office
- NZ · NZ
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-09-14
- Filing Date
- 2021-09-14
- Publication Date
- 2026-09-25
Smart Images
Figure 00000391_0000 
Figure 00000392_0000 
Figure 00000393_0000
Abstract
Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for targeting glucagon-like peptide 1 receptor (GLP1R). In certain embodiments, provided are peptidomimetic payloads and linker-payloads and methods of making same. More specifically, GLP1 peptidomimetics, antibody-drug conjugates, and compositions which comprise anti-GLP1R antibodies and GLP1 peptidomimetic payloads and methods of treating GLP1R-associated conditions are provided.
Need to check novelty before this filing date? Find Prior Art